US$ 29.73
eli lilly oral tirzepatide Lilly's weight loss, diabetes drug tops Keytruda as world's best-selling medicine Doctor shares what to know
Description
Phase 3 Results (REIMAGINE-2, Feb 2026): HbA1c reduction of up to 1.91 points, outperforming semaglutide alone Weight loss of up to 14.2% at 68 weeks in adults with type 2 diabetes and obesity In weight-management evaluation, diabetics achieved ~15.7% weight loss vs 3.1% with placebo Regulatory update: Novo Nordisk filed for FDA approval (Dec 2025) for weight management, supported by the REDEFINE clinical program

Indias drug regulator has issued a strict advisory prohibiting direct and indirect promotion of prescription weight-loss drugs, including digital campaigns, influencer endorsements and disease-awareness initiatives that could act as surrogate advertising
Dry mouth affects many people taking semaglutide for weight loss
It's effective even in outdoor temperatures up to 86F (30C)

It means manufacturing is ready
Semaglutide is a GLP-1 receptor agonist available in three brand names: Ozempic, Wegovy, and Rybelsus